Statistics for Targeting PAR-2-driven inflammatory pathways in colorectal cancer: mechanistic insights from atorvastatin and rosuvastatin treatment in cell line models
Total visits
| views | |
|---|---|
| Targeting PAR-2-driven inflammatory pathways in colorectal cancer: mechanistic insights from atorvastatin and rosuvastatin treatment in cell line models | 5 | 
Total visits per month
| views | |
|---|---|
| April 2025 | 0 | 
| May 2025 | 0 | 
| June 2025 | 2 | 
| July 2025 | 0 | 
| August 2025 | 0 | 
| September 2025 | 1 | 
| October 2025 | 2 | 
File Visits
| views | |
|---|---|
| tcr-14-03-1531.pdf | 3 | 
